{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T05:53:38Z","timestamp":1758347618780,"version":"3.44.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,18]]},"DOI":"10.7759\/cureus.92671","type":"journal-article","created":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T04:37:41Z","timestamp":1758256661000},"source":"Crossref","is-referenced-by-count":0,"title":["Lipid Parameters and Their Association With Liver Function Test Variables in Patients With Type 2 Diabetes Mellitus"],"prefix":"10.7759","author":[{"given":"Sai Venkatram Reddy","family":"Molugu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaitra Reddy","family":"Molugu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hemanth Reddy","family":"Molugu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srinivasa Reddy","family":"Badvel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun H","year":"2022","unstructured":"Sun H, Saeedi P, Karuranga S, et al.. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022, 183:109119. 10.1016\/j.diabres.2021.109119","journal-title":"Diabetes Res Clin Pract"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2019.107842","article-title":"Worldwide estimates of incidence, prevalence and mortality of type 1 diabetes in children and adolescents: results from the International Diabetes Federation Diabetes Atlas, 9th edition","volume":"157","author":"Patterson CC","year":"2019","unstructured":"Patterson CC, Karuranga S, Salpea P, Saeedi P, Dahlquist G, Soltesz G, Ogle GD. Worldwide estimates of incidence, prevalence and mortality of type 1 diabetes in children and adolescents: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019, 157:107842. 10.1016\/j.diabres.2019.107842","journal-title":"Diabetes Res Clin Pract"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-011-2291-5","article-title":"Prevalence of diabetes and prediabetes (impaired fasting glucose and\/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMR-INDIAB) study","volume":"54","author":"Anjana RM","year":"2011","unstructured":"Anjana RM, Pradeepa R, Deepa M, et al.. Prevalence of diabetes and prediabetes (impaired fasting glucose and\/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMR-INDIAB) study. Diabetologia. 2011, 54:3022-7. 10.1007\/s00125-011-2291-5","journal-title":"Diabetologia"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2011.10.029","article-title":"IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030","volume":"94","author":"Whiting DR","year":"2011","unstructured":"Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011, 94:311-21. 10.1016\/j.diabres.2011.10.029","journal-title":"Diabetes Res Clin Pract"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S62320","article-title":"Holistic approach to prevention and management of type 2 diabetes mellitus in a family setting","volume":"7","author":"Ofori SN","year":"2014","unstructured":"Ofori SN, Unachukwu CN. Holistic approach to prevention and management of type 2 diabetes mellitus in a family setting. Diabetes Metab Syndr Obes. 2014, 7:159-68. 10.2147\/DMSO.S62320","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.10.2623","article-title":"Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study","volume":"53","author":"Hanley AJ","year":"2004","unstructured":"Hanley AJ, Williams K, Festa A, et al.. Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes. 2004, 53:2623-32. 10.2337\/diabetes.53.10.2623","journal-title":"Diabetes"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0505","article-title":"Gamma-glutamyltransferase, obesity, and the risk of type 2 diabetes: observational cohort study among 20,158 middle-aged men and women","volume":"89","author":"Lee DH","year":"2004","unstructured":"Lee DH, Silventoinen K, Jacobs DR Jr, Jousilahti P, Tuomileto J. Gamma-glutamyltransferase, obesity, and the risk of type 2 diabetes: observational cohort study among 20,158 middle-aged men and women. J Clin Endocrinol Metab. 2004, 89:5410-4. 10.1210\/jc.2004-0505","journal-title":"J Clin Endocrinol Metab"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-003-1036-5","article-title":"Gamma-glutamyltransferase and diabetes--a 4 year follow-up study","volume":"46","author":"Lee DH","year":"2003","unstructured":"Lee DH, Ha MH, Kim JH, et al.. Gamma-glutamyltransferase and diabetes--a 4 year follow-up study. Diabetologia. 2003, 46:359-64. 10.1007\/s00125-003-1036-5","journal-title":"Diabetologia"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.18295\/squmj.2016.16.02.002","article-title":"Mechanisms of diabetes-induced liver damage: the role of oxidative stress and inflammation","volume":"16","author":"Mohamed J","year":"2016","unstructured":"Mohamed J, Nazratun Nafizah AH, Zariyantey AH, Budin SB. Mechanisms of diabetes-induced liver damage: the role of oxidative stress and inflammation. Sultan Qaboos Univ Med J. 2016, 16:e132-41. 10.18295\/squmj.2016.16.02.002","journal-title":"Sultan Qaboos Univ Med J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/22201009.2011.10872250","article-title":"High prevalence of abnormal liver enzymes in South African patients with type 2 diabetes mellitus attending a diabetes clinic","volume":"16","author":"Paruk IM","year":"2011","unstructured":"Paruk IM, Pirie FJ, Motala AA, Kolawole BA. High prevalence of abnormal liver enzymes in South African patients with type 2 diabetes mellitus attending a diabetes clinic. JEMDSA. 2011, 16:43-7. 10.1080\/22201009.2011.10872250","journal-title":"JEMDSA"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4172\/2157-7013.1000257","article-title":"Diabetes and liver an association: hepatogenous diabetes mechanism and some evidences","volume":"7","author":"Acharya A","year":"2016","unstructured":"Acharya A, Wudneh E, Krishnan R, Ashraf A, Tohid H. Diabetes and liver an association: hepatogenous diabetes mechanism and some evidences. J Cell Sci Ther. 2016, 7:1-6. 10.4172\/2157-7013.1000257","journal-title":"J Cell Sci Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.748157","article-title":"Prevalence, awareness, treatment and control of diabetes in India from the countrywide National NCD Monitoring Survey","volume":"10","author":"Mathur P","year":"2022","unstructured":"Mathur P, Leburu S, Kulothungan V. Prevalence, awareness, treatment and control of diabetes in India from the countrywide National NCD Monitoring Survey. Front Public Health. 2022, 10:748157. 10.3389\/fpubh.2022.748157","journal-title":"Front Public Health"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108078","article-title":"Diabetes and global ageing among 65-99-year-old adults: findings from the International Diabetes Federation Diabetes Atlas, 9(th) edition","volume":"162","author":"Sinclair A","year":"2020","unstructured":"Sinclair A, Saeedi P, Kaundal A, Karuranga S, Malanda B, Williams R. Diabetes and global ageing among 65-99-year-old adults: findings from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract. 2020, 162:108078. 10.1016\/j.diabres.2020.108078","journal-title":"Diabetes Res Clin Pract"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjbs.2016.03.001","article-title":"Prevalence and pattern of dyslipidemia in hyperglycemic patients and its associated factors among Pakistani population","volume":"23","author":"Sarfraz M","year":"2016","unstructured":"Sarfraz M, Sajid S, Ashraf MA. Prevalence and pattern of dyslipidemia in hyperglycemic patients and its associated factors among Pakistani population. Saudi J Biol Sci. 2016, 23:761-6. 10.1016\/j.sjbs.2016.03.001","journal-title":"Saudi J Biol Sci"},{"key":"ref15","article-title":"Prevalence of lipid abnormalities, awareness, and treatment in US adults with diabetes","volume":"49","author":"Fagot-Campagna AN","year":"2000","unstructured":"Fagot-Campagna AN, Rolla DB, Beckles GL, Gregg EW, Narayan KM. Prevalence of lipid abnormalities, awareness, and treatment in US adults with diabetes. Diabetes. 2000, 49:78-9.","journal-title":"Diabetes"},{"key":"ref16","article-title":"Study of prevalence of dyslipidemia in women with diabetes mellitus-a cross sectional study","volume":"4","author":"Shalini M","year":"2014","unstructured":"Shalini M, Suresh Babu KP, Mounika K, Srinivasa Murthy AG. Study of prevalence of dyslipidemia in women with diabetes mellitus-a cross sectional study. Int J Health Sci Res. 2014, 4:95-9.","journal-title":"Int J Health Sci Res"},{"key":"ref17","article-title":"Hepatology-A Clinical Textbook","author":"Mauss S","year":"2014","unstructured":"Mauss S, Berg T, Rockstroh J, Sarrazin C, Wedemeyer H, Kamps BS. Hepatology-A Clinical Textbook. Flying Publisher, Wuppertal; 2014."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-022-01042-2","article-title":"Serum liver enzymes and diabetes from the Rafsanjan cohort study","volume":"22","author":"Noroozi Karimabad M","year":"2022","unstructured":"Noroozi Karimabad M, Khalili P, Ayoobi F, Esmaeili-Nadimi A, La Vecchia C, Jamali Z. Serum liver enzymes and diabetes from the Rafsanjan cohort study. BMC Endocr Disord. 2022, 22:127. 10.1186\/s12902-022-01042-2","journal-title":"BMC Endocr Disord"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.5923\/j.diabetes.20120103.02","article-title":"Determinants of abnormal liver function tests in diabetes patients in Myanmar","volume":"1","author":"Han N","year":"2012","unstructured":"Han N, Soe HK, Htet A. Determinants of abnormal liver function tests in diabetes patients in Myanmar. Int J Diab Res. 2012, 1:36-41. 10.5923\/j.diabetes.20120103.02","journal-title":"Int J Diab Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-1998","article-title":"Clinical utility of creatinine- and cystatin C-based definition of renal function for risk prediction of primary cardiovascular events in patients with diabetes","volume":"35","author":"Sch\u00f6ttker B","year":"2012","unstructured":"Sch\u00f6ttker B, Herder C, M\u00fcller H, Brenner H, Rothenbacher D. Clinical utility of creatinine- and cystatin C-based definition of renal function for risk prediction of primary cardiovascular events in patients with diabetes. Diabetes Care. 2012, 35:879-86. 10.2337\/dc11-1998","journal-title":"Diabetes Care"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.7.3.248","article-title":"Liver function tests in diabetic patients","volume":"7","author":"Salmela PI","year":"1984","unstructured":"Salmela PI, Sotaniemi EA, Niemi M, M\u00e4entausta O. Liver function tests in diabetic patients. Diabetes Care. 1984, 7:248-54. 10.2337\/diacare.7.3.248","journal-title":"Diabetes Care"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/clc.20951","article-title":"Mildly decreased glomerular filtration rate is associated with poor coronary collateral circulation in patients with coronary artery disease","volume":"34","author":"Kadi H","year":"2011","unstructured":"Kadi H, Ceyhan K, Sogut E, Koc F, Celik A, Onalan O, Sahin S. Mildly decreased glomerular filtration rate is associated with poor coronary collateral circulation in patients with coronary artery disease. Clin Cardiol. 2011, 34:617-21. 10.1002\/clc.20951","journal-title":"Clin Cardiol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000432","article-title":"Duration of type 2 diabetes and liver-related events in nonalcoholic fatty liver disease: a landmark analysis","volume":"78","author":"Zhang X","year":"2023","unstructured":"Zhang X, Yip TC, Tse YK, et al.. Duration of type 2 diabetes and liver-related events in nonalcoholic fatty liver disease: a landmark analysis. Hepatology. 2023, 78:1816-27. 10.1097\/HEP.0000000000000432","journal-title":"Hepatology"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2011.02482.x","article-title":"Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors","volume":"31","author":"Leite NC","year":"2011","unstructured":"Leite NC, Villela-Nogueira CA, Pannain VL, Bottino AC, Rezende GF, Cardoso CR, Salles GF. Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors. Liver Int. 2011, 31:700-6. 10.1111\/j.1478-3231.2011.02482.x","journal-title":"Liver Int"},{"key":"ref25","article-title":"Alkaline phosphatase: can it be considered as an indicator of liver fibrosis in non-alcoholic steatohepatitis with type 2 diabetes?","volume":"112","author":"Kocabay G","year":"2011","unstructured":"Kocabay G, Telci A, Tutuncu Y, et al.. Alkaline phosphatase: can it be considered as an indicator of liver fibrosis in non-alcoholic steatohepatitis with type 2 diabetes?. Bratisl Lek Listy. 2011, 112:626-9.","journal-title":"Bratisl Lek Listy"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-004-1460-1","article-title":"Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk","volume":"47","author":"Westerbacka J","year":"2004","unstructured":"Westerbacka J, Corn\u00e9r A, Tiikkainen M, et al.. Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk. Diabetologia. 2004, 47:1360-9. 10.1007\/s00125-004-1460-1","journal-title":"Diabetologia"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/401249-lipid-parameters-and-their-association-with-liver-function-test-variables-in-patients-with-type-2-diabetes-mellitus","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T04:37:42Z","timestamp":1758256662000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/401249-lipid-parameters-and-their-association-with-liver-function-test-variables-in-patients-with-type-2-diabetes-mellitus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,18]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.92671","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,9,18]]}}}